These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 15204640)

  • 1. Microencapsulation of superoxide dismutase into biodegradable microparticles by spray-drying.
    Youan BB
    Drug Deliv; 2004; 11(3):209-14. PubMed ID: 15204640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microencapsulation of superoxide dismutase into poly(epsilon-caprolactone) microparticles by reverse micelle solvent evaporation.
    Youan BB
    Drug Deliv; 2003; 10(4):283-8. PubMed ID: 14612345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microencapsulation of cytarabine using poly(ethylene glycol)-poly(epsilon-caprolactone) diblock copolymers as surfactant agents.
    Diab R; Hamoudeh M; Boyron O; Elaissari A; Fessi H
    Drug Dev Ind Pharm; 2010 Apr; 36(4):456-69. PubMed ID: 19877831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein release profiles and morphology of biodegradable microcapsules containing an oily core.
    Youan BB; Jackson TL; Dickens L; Hernandez C; Owusu-Ababio G
    J Control Release; 2001 Oct; 76(3):313-26. PubMed ID: 11578745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymeric microspheres prepared by spraying into compressed carbon dioxide.
    Bodmeier R; Wang H; Dixon DJ; Mawson S; Johnston KP
    Pharm Res; 1995 Aug; 12(8):1211-7. PubMed ID: 7494836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of formulation variables on the morphology of biodegradable microparticles prepared by spray drying.
    Clarke N; O'Connor K; Ramtoola Z
    Drug Dev Ind Pharm; 1998 Feb; 24(2):169-74. PubMed ID: 15605447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of single or blended polymer types for controlled in vitro release and plasma levels of a somatostatin analogue entrapped in PLA/PLGA microspheres.
    Blanco-Príeto MJ; Campanero MA; Besseghir K; Heimgatner F; Gander B
    J Control Release; 2004 May; 96(3):437-48. PubMed ID: 15120900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biodegradable pseudolatexes: the chemical stability of poly(D,L-lactide) and poly(epsilon-caprolactone) nanoparticles in aqueous media.
    Coffin MD; McGinity JW
    Pharm Res; 1992 Feb; 9(2):200-5. PubMed ID: 1553342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary investigation on the design of biodegradable microparticles for ivermectin delivery: set up of formulation parameters.
    Dorati R; Genta I; Colzani B; Tripodo G; Conti B
    Drug Dev Ind Pharm; 2015; 41(7):1182-92. PubMed ID: 24994001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of various technological parameters on the preparation of spray-dried poly(epsilon-caprolactone) microparticles containing a model antigen.
    Baras B; Benoit MA; Gillard J
    J Microencapsul; 2000; 17(4):485-98. PubMed ID: 10898088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation of biodegradable poly(+/-)lactide microparticles using a spray-drying technique.
    Bodmeier R; Chen HG
    J Pharm Pharmacol; 1988 Nov; 40(11):754-7. PubMed ID: 2907552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of sucrose esters as alternative surfactants in microencapsulation of proteins by the solvent evaporation method.
    Youan BB; Hussain A; Nguyen NT
    AAPS PharmSci; 2003; 5(2):E22. PubMed ID: 12866947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parameters influencing the antigen release from spray-dried poly(DL-lactide) microparticles.
    Baras B; Benoit MA; Gillard J
    Int J Pharm; 2000 Apr; 200(1):133-45. PubMed ID: 10845695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel in situ forming drug delivery system for controlled parenteral drug delivery.
    Kranz H; Bodmeier R
    Int J Pharm; 2007 Mar; 332(1-2):107-14. PubMed ID: 17084049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small-molecule release from poly(D,L-lactide)/poly(D,L-lactide-co-glycolide) composite microparticles.
    Pollauf EJ; Kim KK; Pack DW
    J Pharm Sci; 2005 Sep; 94(9):2013-22. PubMed ID: 16052542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the microencapsulation of nanoparticles on the reduction of burst release.
    Hasan AS; Socha M; Lamprecht A; Ghazouani FE; Sapin A; Hoffman M; Maincent P; Ubrich N
    Int J Pharm; 2007 Nov; 344(1-2):53-61. PubMed ID: 17643878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poly (epsilon-caprolactone)/propolis extract: microencapsulation and antibacterial activity evaluation.
    Durán N; Marcato PD; Buffo CM; De Azevedo MM; Esposito E
    Pharmazie; 2007 Apr; 62(4):287-90. PubMed ID: 17484285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of protein loaded poly(epsilon-caprolactone) microparticles prepared by the hot-melt technique.
    Lin WJ; Yu CC
    J Microencapsul; 2001; 18(5):585-92. PubMed ID: 11508764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microencapsulation of hydrophilic drug substances using biodegradable polyesters. Part II: Implants allowing controlled drug release--a feasibility study using bisphosphonates.
    Weidenauer U; Bodmer D; Kissel T
    J Microencapsul; 2004 Mar; 21(2):137-49. PubMed ID: 15198426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrasonic atomization and subsequent polymer desolvation for peptide and protein microencapsulation into biodegradable polyesters.
    Felder ChB; Blanco-Príeto MJ; Heizmann J; Merkle HP; Gander B
    J Microencapsul; 2003; 20(5):553-67. PubMed ID: 12909541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.